Seven Eight Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,935
| Closed | -$486K | – | 740 |
|
|
2024
Q1 | $486K | Sell |
6,935
-55,294
| -89% | -$3.88M | 0.05% | 458 |
|
|
2023
Q4 | $5.2M | Buy |
+62,229
| New | +$5.2M | 0.6% | 41 |
|
|
2023
Q2 | – | Sell |
-9,443
| Closed | -$332K | – | 535 |
|
|
2023
Q1 | $332K | Buy |
+9,443
| New | +$332K | 0.07% | 315 |
|
|
2022
Q4 | – | Sell |
-7,907
| Closed | -$383K | – | 458 |
|
|
2022
Q3 | $383K | Sell |
7,907
-12,920
| -62% | -$626K | 0.08% | 326 |
|
|
2022
Q2 | $818K | Buy |
+20,827
| New | +$818K | 0.33% | 108 |
|
|
2022
Q1 | – | Sell |
-8,979
| Closed | -$409K | – | 559 |
|
|
2021
Q4 | $409K | Buy |
8,979
+1,279
| +17% | +$58.3K | 0.07% | 304 |
|
|
2021
Q3 | $275K | Buy |
+7,700
| New | +$275K | 0.03% | 507 |
|
|
2020
Q4 | – | Sell |
-28,800
| Closed | -$624K | – | 452 |
|
|
2020
Q3 | $624K | Buy |
+28,800
| New | +$624K | 0.13% | 292 |
|